http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010537658-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2008-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010537658-A |
| titleOfInvention | Methods and tools for determining the prognosis of cancer in HER2 + patients |
| abstract | At least one, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen selected from Table 12 and / or Table 13 14、15、16、17、18、19、20、21、22、23、24、25、26、27、28、29、30 , 31, 32, 33, 34, 35, and optionally 40, 45, 50, 55, 60, 65 genes or proteins, or the entire set, and A gene set or protein set comprising or consisting of antibodies directed against the proteins encoded by these genes or hypervariable portions thereof. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016516426-A |
| priorityDate | 2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.